Optimizing Genetic Health Risk Testing: The Power of Preanalytical Systems

NOW AVAILABLE ON DEMAND!

Developing reliable genetic health risk tests requires more than just strong assay design—it depends on high-quality samples and efficient workflows from the start. Clinical laboratories often face challenges in maintaining sample integrity, streamlining test development, and ensuring accurate, actionable results for patients.

In this webinar, experts from DNA Genotek and Targeted Genomics will present a real-world case study that highlights how integrating validated sample collection devices into a genetic health risk test improved test performance, reliability, and accessibility.

Join Today’s Clinical Lab and featured speakers Shelly Gunn, Jonathan Chan and Tara Crawford Parks for an in-depth discussion on:

• The value of Genetic Health Risk (GHR) tests in expanding patient and provider access to clinically meaningful genomic data that supports personalized care.
• How high-quality sample collection—a critical pre-analytical factor—directly impacts genetic test performance, reliability, and patient outcomes.
• The benefits of using validated sample collection devices with demonstrated usability and technical performance in genetic testing workflows.
• Practical insights into incorporating preanalytical systems into assay development, validation, and commercialization strategies.

Learn how a thoughtful preanalytical approach can drive better test performance, greater efficiency, and broader patient access in the rapidly evolving world of genetic diagnostics.